HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Invacare Names Interim President and CEO

September 1, 2022 by David Kopf

HME manufacturer Invacare Corp. has made a major change to its leadership, naming a new interim President and CEO, as well as changes to its board of directors.

Geoffrey Purtill will cast off his role as SVP and general manager of Invacare’s Asia Pacific and Europe, Middle East, and Africa businesses to lead the company as its interim president and CEO. Invacare tapped Purtill for the leadership spot after Matthew Monaghan exited his role as chairman, president and CEO on Aug. 28.

“We welcome Geoff, who has distinguished himself throughout his tenure with Invacare,” said Cliff Nastas, Invacare’s lead independent director. “The Board has full confidence that he has the right skillset and industry experience to lead the company through this transition as we search for a permanent successor who can accelerate the achievement of our objectives.”

Invacare’s Board of Directors has already launched a search to identify and appoint a permanent CEO.

Invacare also appointed Michael Merriman, Jr. as a director and named non-executive chairman of the board. Merriman previously served on Invacare’s Board and was chair of its Audit Committee from 2014 to 2018. Merriman will also serve on the company’s Strategy Committee. As the independent chairman of the board, Merriman succeeds Cliff Nastas as the company’s lead independent director.

“We are excited to welcome Mike Merriman back to the Board and know that his leadership, financial and business management acumen and experience in transforming underperforming businesses will be invaluable to the Board as we transform Invacare,” Nastas said.

Related Articles Read More >

Temporary Restraining Order Reinstates BOC as Accrediting Organization
The reinstatement is effective Jan. 9, 2025.
Fisher & Paykel’s F&P Nova Nasal Mask Now Available in US
The new mask is designed to support easy fitting and sound sleep for sleep apnea patients.
‘Common Sense’ Home Infusion Reform Discussed at Congressional Subcommittee Hearing
NHIA CEO Connie Sullivan urged House members to support the Preserving Patient Access to Home Infusion Act.
AAHomecare CEO to Congressional Subcommittee: ‘We Believe 37% of the Industry Has Gone Out of Business’
Tom Ryan testified about three durable medical equipment bills on Jan. 8.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe